IDH1 and IDH2 mutation studies in 1473 patients with chronic-, fibrotic- or blast-phase essential thrombocythemia, polycythemia vera or myelofibrosis
TEFFERI, A ; LASHO, T. L ; MAI, M ; MCCLURE, R. F ; GILLILAND, D. G ; LEVINE, R. L ; PARDANANI, A ; VANNUCCHI, A. M ; ABDEL-WAHAB, O ; GUGLIELMELLI, P ; PATEL, J ; CARAMAZZA, D ; PIERI, L ; FINKE, C. M ; KILPIVAARA, O ; WADLEIGH, M
Leukemia, 2010-07, Vol.24 (7), p.1302-1309 [Periódico revisado por pares]Avenel, NJ: Nature Publishing Group
Texto completo disponível